Literature DB >> 3259853

Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography.

S Gilman1, D S Markel, R A Koeppe, L Junck, K J Kluin, S S Gebarski, R D Hichwa.   

Abstract

We studied local cerebral metabolic rates for glucose (1CMRglc) with 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography (PET) in 30 patients with olivopontocerebellar atrophy (OPCA) and 30 age-matched control subjects without neurological disease. The diagnosis of OPCA was based on the history and physical findings and on the exclusion of other causes of cerebellar ataxia by means of laboratory investigations. Computed tomographic scans revealed some degree of atrophy of the cerebellum in most patients with OPCA, and many also had atrophy of the brainstem. PET studies in these patients revealed significant hypometabolism in the cerebellar hemispheres, cerebellar vermis, and brainstem in comparison with the normal control subjects. A significant relationship was found between the degree of atrophy and the level of 1CMRglc in the cerebellum and brainstem. Nevertheless, several patients had minimal atrophy and substantially reduced 1CMRglc, suggesting that atrophy does not fully account for the finding of hypometabolism. 1CMRglc was within normal limits for the thalamus and cerebral cortex. The data suggest that PET/1CMRglc may be useful as a diagnostic test in patients with the adult onset of cerebellar ataxia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259853     DOI: 10.1002/ana.410230303

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

Review 1.  Brain SPECT imaging in multiple system atrophy.

Authors:  R Cilia; G Marotta; R Benti; G Pezzoli; A Antonini
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

2.  The role of MRI in the diagnosis of olivopontocerebellar atrophy.

Authors:  G Giuliani; L Chiaramoni; N Foschi; S Terziani
Journal:  Ital J Neurol Sci       Date:  1992-03

3.  A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism (Niccolini and Politis, 2016) : Reply to Jean-Claude Baron Letter to Editor.

Authors:  Marios Politis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03       Impact factor: 9.236

4.  A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism.

Authors:  Jean-Claude Baron
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-15       Impact factor: 9.236

5.  Quantitative evaluation of pontine atrophy using computer tomography.

Authors:  K Chida; N Goto; I Kamikura; T Takasu
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

6.  Positron emission tomography in asymptomatic gene carriers of Machado-Joseph disease.

Authors:  B W Soong; R S Liu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

7.  Altered structural connectivity of the motor subnetwork in multiple system atrophy with cerebellar features.

Authors:  Apurva Shah; Shweta Prasad; Bharti Rastogi; Santosh Dash; Jitender Saini; Pramod Kumar Pal; Madhura Ingalhalikar
Journal:  Eur Radiol       Date:  2018-12-14       Impact factor: 5.315

8.  Demonstration of abnormal perfusion in the pons with high resolution SPECT and technetium-99m HMPAO in a patient with acoustic neuroma.

Authors:  N Yui; T Togawa; F Kinoshita; H Namba; Y Akiyama
Journal:  Ann Nucl Med       Date:  1993-08       Impact factor: 2.668

9.  Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.

Authors:  N L Foster; S Gilman; S Berent; A A Sima; C D'Amato; R A Koeppe; S P Hicks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

10.  Multiple system atrophy. Clinical and MR observations on 42 cases.

Authors:  D Testa; M Savoiardo; V Fetoni; L Strada; E Palazzini; G Bertulezzi; F Girotti
Journal:  Ital J Neurol Sci       Date:  1993-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.